Literature DB >> 11787867

Immunological status of thalassemia syndrome.

Ustün Ezer1, Ferda Gülderen, Vildan K Culha, Nursen Akgül, Ozlem Gürbüz.   

Abstract

A major cause of morbidity and mortality in thalassemic patients is infections, assumed to be the result of immunological changes. In this study immune functions of peripheral blood lymphocytes have been studied in 38 beta-thalassemia major, 12 beta-thalassemia trait, and 17 healthy children. Results show decrease in CD4+/CD8+ ratios in the beta-thalassemia major group and no difference according to absolute T-lymphocyte numbers and activated T-cell numbers. These results do not correlate with the tendency to infection. No significant difference was found in humoral immunity. The study of other factors in thalassemia is needed to detect those who are more susceptible to infections.

Entities:  

Mesh:

Year:  2002        PMID: 11787867     DOI: 10.1080/088800102753356194

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  13 in total

1.  Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major.

Authors:  Asmaa M Zahran; Khaled Saad; Khalid I Elsayh; Mohamd A Alblihed
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

2.  Rheumatoid arthritis in patients with hemoglobinopathies.

Authors:  Xanthi I Pliakou; Frideriki P Koutsouka; Dimitrios Damigos; Konstantinos L Bourantas; Evangelos C Briasoulis; Paraskevi V Voulgari
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

3.  Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Authors:  Brigitta Buttari; Elisabetta Profumo; Patrizia Caprari; Sara Massimi; Francesco Sorrentino; Laura Maffei; Marco Gabbianelli; Rachele Riganò
Journal:  Ann Hematol       Date:  2020-08-15       Impact factor: 3.673

4.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

5.  Immunity to tetanus in major beta thalassemia patients.

Authors:  Abdolreza Sotoodeh Jahromi; Karamatollah Rahmanian
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

6.  Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  Asian J Transfus Sci       Date:  2017 Jan-Jun

7.  Red blood cells exposed to cancer cells in culture have altered cytokine profiles and immune function.

Authors:  Elisabeth Karsten; Edmond Breen; Sharon A McCracken; Stephen Clarke; Benjamin R Herbert
Journal:  Sci Rep       Date:  2020-05-07       Impact factor: 4.379

Review 8.  Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.

Authors:  Hadi Darvishi Khezri; Ebrahim Salehifar; Mehrnoush Kosaryan; Aily Aliasgharian; Hossein Jalali; Arash Hadian Amree
Journal:  Adv Pharmacol Sci       Date:  2016-02-21

9.  Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients.

Authors:  Hamid Najmaddini; Gholamhossein Hassanshahi; Hamid Ostadebrahimi; Hoda Barkhordari; Habibeh Mashayekhi; Mina Nazari; Mozhgan Moogooei; Yassin Safari Arababadi; Fatemeh Peighambari; Mojgan Noroozi Karimabad
Journal:  Ann Saudi Med       Date:  2014 Mar-Apr       Impact factor: 1.526

10.  Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Yasmeen H Mady; Essam Eldeen M O Mahran; Alaa Rashad; Ahmed Makboul; Khalid A Nasif; Aida A Abdelmaksoud; Omnia El-Badawy
Journal:  Multidiscip Respir Med       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.